Flow cytometric analysis of micronuclei in peripheral blood reticulocytes III. An efficient method of monitoring chromosomal damage in the beagle dog

Toxicological Sciences

Volumn 100, Issue 2, 2007, Pages 406-414

  Harper, Susan B ^a,e   Dertinger, Stephen D ^b   Bishop, Michelle E ^c   Lynch, Anthony M ^d   Lorenzo, Maria ^e,g   Saylor, Michelle ^e,h   MacGregor, James T ^e,f  

^a DEPARTMENT OF VETERANS AFFAIRS   (United States)

^b LITRON LABORATORIES   (United States)

^c NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^d GLAXOSMITHKLINE   (United Kingdom)

^e CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^f Toxicology Consulting Services   (United States)

^g JOHNS HOPKINS UNIVERSITY   (United States)

^h UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

Author keywords

Blood; Bone marrow; Chromosomal damage; Flow cytometry; Micronucleus; Reticulocytes

Indexed keywords

ACRIDINE ORANGE; CD71 ANTIGEN; CYCLOPHOSPHAMIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOOD CELL; BONE MARROW CELL; BONE MARROW ERYTHROCYTE MICRONUCLEUS ASSAY; CHROMOSOME BREAKAGE; CORRELATION ANALYSIS; DOG; FEMALE; FLOW CYTOMETRY; GENOTOXICITY; MALE; MICRONUCLEUS TEST; MICROSCOPY; NONHUMAN; PLASMODIUM BERGHEI; RETICULOCYTE; SCORING SYSTEM; SENSITIVITY ANALYSIS; STANDARDIZATION; TOXIN ANALYSIS;

ANIMALS; BONE MARROW; BONE MARROW CELLS; CYCLOPHOSPHAMIDE; DOGS; FEMALE; FLOW CYTOMETRY; MALE; MICRONUCLEI, CHROMOSOME-DEFECTIVE; MICRONUCLEUS TESTS; MUTAGENS; REPRODUCIBILITY OF RESULTS; RETICULOCYTES;

CANIS FAMILIARIS; MUS; PLASMODIUM BERGHEI; RATTUS;

EID: 36248959767     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfm241     Document Type: Article

References (34)

1. Abramsson-Zetterberg, L., Zetterberg, G., Bergqvist, M., and Grawé, J. (2000). Human cytogenetic biomonitoring using flow-cytometric analysis of micronuclei in transferrin-positive immature peripheral blood erythrocytes. Environ. Mol. Mutagen. 36, 22-31.
2. D'Arcy, P. F., and Harron, D. W. G. (1998). ICH harmonized tripartite guidelines: "Guideline on specific aspects of regulatory genotoxicity tests for pharmaceuticals (S2A)" and "Genotoxicity: A standard battery for gepotoxicity testing of pharmaceuticals (S2B)". In Proceedings of the Fourth International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (P. F. D'Arcy and D. W. G. Harron, Eds.), pp. 973-998. Greystone Books Ltd., Antrium, North Ireland.
3. Dertinger, S. D., Bishop, M. E., McNamee, J. P., Hayashi, M., Suzuki, T., Asano, N., Nakajima, M., Saito, J., Moore, M., Torous, D. K., et al. (2006). Flow cytometric analysis of micronuclei in peripheral blood reticulocytes: I. intra- and inter-laboratory comparison with microscopic scoring. Toxicol. Sci. 94, 83-91.
4. Dertinger, S. D., Camphausen, K., MacGregor, J. T., Bishop, M. E., Torous, D. K., Avlasevich, S., Cairns, S., Tometsko, C. R., Menard, C., Muanza, T., et al. (2004). Three-color labeling method for flow cytometric measurement of cytogenetic damage in rodent and human blood. Environ. Mot. Mutagen. 44, 427-435.
5. Dertinger, S. D., Chen, Y., Miller, R. K., Brewer, K. J., Smudzin, T., Torous, D. K., Hall, N. E., Olvany, K. A., Murante, F. G., and Tometsko, C. R. (2003). Micronucleated CD71-positive reticulocytes: A blood-based endpoint of cytogenetic damage in humans. Mutat. Res. 542, 77-85.
6. Dertinger, S. D., Miller, R. K., Brewer, K., Smudzin, T., Torous, D. K., Roberts, D. J., Avlasevich, S. L., Bryce, S. M., Sugunan, S., and Chen, Y. (2007). Automated human blood micromicleated reticulocyte measurements for rapid assessment of chromosomal damage. Mutat. Res. 626, 111-119.
7. Dertinger, S. D., Torous, D. K., Hall, N. E., Tometsko, C. R., and Gasiewicz, T. A. (2000). Malaria-infected erythrocytes serve as biological standards to ensure reliable and consistent scoring of micronucleated erythrocytes by flow cytometry. Mutat. Res. 464 195-200.
8. Everson, R. B., Wehr, C. M., Erexson, G. L., and MacGregor, J. T. (1988). Association of marginal folate depletion with increased human chromosomal damage in vivo: Demonstration by analysis of micromicleated erythrocytes. J. Natl. Cancer Inst. 80, 525-529.
9. FDA (U.S. Food and Drug Administration) (2000). Office of Food Additive Safety, Redbook 2000, Toxicological Principles for Safety Assessment of Food Ingredients. Available at: http://www.cfsan.fda.gov/~redbook/redtoca.html. Accessed November 2003.
10. Grawé, J., Biko, J., Lorenz, R., Reiners, C., Stopper, H., Vershenya, S., Vukicevic, V., and Hempel, K. (2005). Evaluation of the reticulocyte micronucleus assay in patients treated with radioiodine for thyroid cancer. Mutat. Res. 583, 12-25.
11. Hamada, S., Sutou, S., Morita, T., Wakata, A., Asanami, S., Hosoya, S., Ozawa, S., Kondo, K., Nakajima, M., Shimada, H., et al. (2001). Evaluation of the rodent micronucleus assay by a 28-day treatment protocol: Summary of the 13th collaborative study by the collaborative study group for the micronucleus test (CSGMT)/Environmental Mutagen Society of Japan (JEMS) - Mammalian Mutagenicity Study Group (MMS). Environ. Mol. Mutagen. 37, 93-110.
12. Hayashi, M., Sofuni, T., and Ishidate, M., Jr (1983). An application of acridine orange fluorescent staining to the micronucleus test. Mutat. Res. 120, 241-247.
13. International Conference on Harmonization (ICH). (1995a). Genotoxicity; A Standard Battery for Genotoxicity Testing of Pharmaceuticals (7/16/1995a).
14. International Conference on Harmonization (ICH). (1995b). Guidance on Specific Aspects of Regulatory Genotoxicity Tests for Pharmaceuticals (7/19/1995b).
15. Kastenbaum, M. A., and Bowman, K. O. (1970). Tables for-determining the statistical significance of mutation frequencies. Mutat. Res: 9 527-549.
16. MacGregor, J. T., Bishop, M. E., McNamee, J. P., Hayashi, M., Asano, N., Wakata, A., Nakajima, M., Aidoo, A., Moore, M. M., and Dertinger, S. D. (2006). Flow cytometric analysis of micronuclei in peripheral blood reticulocytes: II. An efficient method of monitoring chromosomal damage in the rat. Toxicol. Sci. 94, 92-107.
17. MacGregor, J. T., O'Loughlin, K. G., and Hill, J. R. (1992). Micronucleated erythrocytes in bone marrow and peripheral blood of the beagle dog. Environ. Mutagen. 19(Suppl. 20), 38. (Abstract).
18. MacGregor, J. T., Wehr, C. M., Henika, P. R., and Shelby, M. D. (1990). The in vivo erythrocyte micronucleus test: Measurement at steady state increases assay efficiency and permits integration with toxicity studies. Fundam. Appl. Toxicol. 14, 513-522.
19. MacGregor, J. T., Wehr, C. M., and Gould, D. H. (1980). Clastogen-induced micronuclei in peripheral blood erythrocytes: The basis of an improved micromicleus test. Environ. Mutagen. 2, 509-514.
20. National Research Council. (1996). Guide for the Care and Use of Laboratory Animals. National Academy Press, Washington, D.C.
21. OECD (1997). Guideline for the Testing of Chemicals. Mammalian Erythrocyte Micronucleus Test. Guideline 474. Organization for Economic Cooperation and Development. Paris, July, 1997.
22. Offer, T., Ho, E., Traber, M. G., Bruno, R. S., Kuypers, F. A., and Ames, B. N. (2005). A simple assay for frequency of chromosome breaks and loss (micronuclei) by flow cytometry of human reticulocytes. FASEB J. 19, 485-487.
23. Plumb, D. C. (2002). Veterinary Drug Handbook, Fourth Edition. Iowa State Press, Ames, IA.
24. Schlegel, R., and MacGregor, J. T. (1984). The persistence of micronucleated erythrocytes in the peripheral circulation of normal and splenectomized Fisher 344 rats: Implications for cytogenetic screening. Mutat. Res. 127, 169-174.
25. Schlegel, R., MacGregor, J. T., and Everson, R. B. (1986). Assessment of cytogenetic damage by quantitation of micromiclei in human peripheral blood erythrocytes. Cancer Res. 46, 3717-3721.
26. Schmid, W. (1976). The micronucleus test for cytogenetic analysis. In Chemical Mutagens, Vol. 4 (A. Hollaender, Ed.), pp. 31-53, Plenum Press, N.Y.
27. Stopper, H., Hempel, K., Reiners, C., Vershenya, S., Lorenz, R., Vukicevic, V., Heidland, A., and Grawé, J. (2005). Pilot study for comparison of reticulocyte-micronuclei with lymphocyte-micronuclei in human biomonitoring. Toxicol. Lett. 156, 351-360.
28. Tometsko, A. M., Torous. D. K., and Dertinger, S. D. (1993). Analysis of micronucleated cells by flow cytometry. 1. Achieving high resolution with a malaria model. Mutat. Res. 292, 129-135.
29. Torous, D. K., Hall, N. E., Dertinger, S. D., Diehl, M. S. Illi-Love, A. H., Cederbrant, K., Sandelin, K., Bolcsfoldi, G., Ferguson, L. R., Pearson, A., et al. (2001). Flow cytometric enumeration of micronucleated reticulocytes: High transferability among 14 laboratories. Environ. Mol. Mutagen. 38, 59-68.
30. Torous, D. K., Hall, N. E., Illi-Love, A. H., Diehl, M. S., Cederbrant, K., Sandelin, K., Pontén, I., Bolcsfoldi, G., Ferguson, L. R., Pearson, A., et al. (2005). Interlaboratory validation of a CD71 based flow cytometric method (MicroFlow®) for the scoring of micronucleated reticulocytes in mouse peripheral blood. Environ. Mol. Mutagen. 45, 44-55.
31. Torous, D. K., Hall, N. E., Murante, F. G., Gleason, S. E., Tometsko, C. R., and Dertinger, S. D. (2003). Comparative scoring of micronucleated reticulocytes in rat peripheral blood by flow cytometry and microscopy. Toxicol. Sci. 74, 309-314.
32. U.S. Environmental Protection Agency (U.S. EPA). (1998). Health Effects Test Guidelines OPPTS 870.5395, Mammalian Erythrocyte Micronucleus Test, Office of Prevention, Pesticides and Toxic Substances (7101). EPA 712-C-98-226, August 1998. Available at: http://www.epa.gov/opptsfrs/publications/OPPTS_Harmonized/ 870_Health_Effects_Test_Guidehnes/Series/870-5395.pdf.
33. Witt, K. L., Cunningham, C. K., Patterson, K. B., Kissling, G. E., Dertinger, S. D., Livingston, E., and Bishop, J. B. (2007). Elevated frequencies of micrunucleated erythrocytes in infants exposed to zidovudine in utero and postpartum to prevent mother-to-child transmission of HIV. Environ. Mol. Mutagen. 48, 322-329.
34. Witt, K. L., Knapton, A., Wehr, C. M., Hook, G. J., Mirsalis, J., Shelby, M. D., and MacGregor, J. T. (2000). Micronucleated erythrocyte frequency in peripheral blood of B6C3F1 mice from short-term, prechronic and chronic studies of the NTP carcinogenesis bioassay program. Environ. Mol. Mutagen. 36, 163-194.